Oral Hemoglobin Delivery via Enteric Coating and Nanoparticles
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current hemoglobin-based oxygen carriers (HBOCs) face challenges with degradation in the stomach and poor absorption due to their molecular weight and hydrophilicity, limiting their effectiveness for oral delivery, especially in non-hospital settings where conditions like high altitude syndrome require enhanced tissue oxygenation.
Innovation Solution
Development of hemoglobin-loaded nanoparticles, enteric-coated capsules, and tablets that protect hemoglobin from acid degradation and facilitate absorption in the intestinal tract, using polyelectrolyte complexes and chitosan to ensure bioavailability and bio-compatibility, with optional excipients for controlled release.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If hemoglobin is administered orally, then convenience of delivery is improved, but degradation in stomach acid and poor absorption occur
Solution Approach 1:
The invention segments the delivery system into multiple protective layers: enteric coating on capsules/tablets protects from stomach acid, while nanoparticle encapsulation provides additional protection and facilitates intestinal absorption. This multi-layer segmentation allows oral administration convenience while maintaining hemoglobin stability through the harsh gastrointestinal environment.
Solution Approach 2:
The invention introduces intermediary materials including enteric coating polymers that resist stomach acid, nanoparticle carriers that protect hemoglobin during transit, and absorption enhancers that facilitate intestinal uptake. These intermediaries mediate between the vulnerable hemoglobin and the harsh gastrointestinal environment, enabling stable oral delivery.
2Reliability
If hemoglobin is stabilized and purified for intravenous use, then safety is improved, but complexity of formulation and administration increases
Solution Approach 1:
The invention extracts hemoglobin from the complexity of intravenous formulation requirements by developing an oral delivery system that bypasses the need for sterile injection protocols, hospital settings, and complex intravenous formulations. This extraction simplifies administration while maintaining safety through the protective delivery system.
Solution Approach 2:
The invention changes the administration route parameter from intravenous to oral, which fundamentally alters the formulation requirements. Instead of needing sterile, pyrogen-free intravenous formulations, the oral system uses enteric coatings and nanoparticle encapsulation, changing the protective parameters while simplifying overall administration complexity.
3Quantity of substance
If hemoglobin is delivered as free protein, then absorption might be improved, but degradation by stomach acid and proteases increases
Solution Approach 1:
The invention provides beforehand cushioning through enteric coating that protects hemoglobin from stomach acid before absorption occurs. The coating is designed to dissolve only in the alkaline environment of the intestine, providing prior protection against acid degradation and proteolytic enzymes during the critical transit phase through the stomach.
Solution Approach 2:
The invention uses flexible protective shells including enteric coating films on capsules and tablets, and nanoparticle encapsulation films. These thin film structures provide selective protection - impermeable to stomach acid and proteases during transit, but permeable to allow hemoglobin release and absorption in the intestinal environment.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The formulations achieve substantial undegraded hemoglobin delivery, increasing oxygen transport and reducing side effects, effectively treating conditions such as high altitude syndrome, anemia, and hypoxic disorders through enhanced bioavailability and controlled oxygen release.
Implementation Method 1
enteric-coated capsules, and tablets that protect hemoglobin from acid degradation
Implementation Method 2
using polyelectrolyte complexes and chitosan to ensure bioavailability and bio-compatibility
Data Source
AI summary
A process for making hemoglobin based oxygen carrier (HBOC) containing pharmaceutical composition suitable for oral delivery and the composition formed thereby are described. There are three exemplary composition configurations which include (1) hemoglobin-loaded nanoparticles solution, (2) enteric-coated hemoglobin capsules and (3) enteric-coated hemoglobin tablets. To facilitate the bioavailability and bio-compatibility of hemoglobin, intestinal absorption enhancers are added in each of the HBOC formulations. Protective layers ensure delivery of an intact hemoglobin structure in intestinal tract without degradation in the stomach. The HBOC formulations may be used for preventive or immediate treatment of high altitude syndrome (HAS) or for treatment of hypoxic conditions including blood loss, anemia, hypoxic cancerous tissue, and other oxygen-deprivation disorders. In addition to delivering oxygen, the heme group of hemoglobin from HBOC formulations can provide heme iron to the human body to aid in the production of more red blood cells.